LA | |
---|---|
Post | - |
Pre | - |
M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | 12.0 | - | - | - | - | 220.5 | 94.0 | 2.5 | - | - | 329 |
1 | 0.5 | - | - | - | - | 29.5 | 9.0 | - | - | - | 39 |
LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
---|---|---|---|---|---|---|---|---|
Post | - | - | - | - | - | - | - | - |
Pre | - | - | - | - | - | - | - | - |
AME | |
---|---|
0 | 312.0 |
1 | 15.5 |
LOP1 | LOP2 | LOP3 | LOP4 | Total | |
---|---|---|---|---|---|
Post | - | - | - | - | - |
Pre | - | - | - | - | - |
central brain | |
---|---|
0 | 171.5 |
1 | 130.0 |
Number of post synapses: 658
Number of pre synapses: 78
Number of output connections: 223
Coverage factor: 1.4
Columnar completeness: 0.15
Area completeness: 0.15
Cell size (columns): 90
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
instance | NT | total connections | connections /#aMe10 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | aMe5 (R) | ACh | 245 | 122.5 | 15.9% | 15.9% |
1 | aMe30 (R) | Glu | 107 | 53.5 | 7.0% | 22.9% |
2 | aMe6c (R) | Glu | 94 | 47.0 | 6.1% | 29.0% |
3 | aMe10 (L) | ACh | 86 | 43.0 | 5.6% | 34.6% |
4 | aMe6b (R) | ACh | 81 | 40.5 | 5.3% | 39.9% |
5 | aMe2 (R) | Glu | 77 | 38.5 | 5.0% | 44.9% |
6 | Cm5 (R) | GABA | 54 | 27.0 | 3.5% | 48.4% |
7 | MeVP5 (R) | unclear | 51 | 25.5 | 3.3% | 51.7% |
8 | Cm6 (R) | GABA | 47 | 23.5 | 3.1% | 54.7% |
9 | MeLo1 (R) | ACh | 47 | 23.5 | 3.1% | 57.8% |
10 | Mi10 (R) | ACh | 47 | 23.5 | 3.1% | 60.9% |
11 | Mi15 (R) | ACh | 46 | 23.0 | 3.0% | 63.8% |
12 | MeTu1 (R) | ACh | 37 | 18.5 | 2.4% | 66.3% |
13 | SLP250 (R) | unclear | 33 | 16.5 | 2.1% | 68.4% |
14 | Dm-DRA1 (R) | Glu | 31 | 15.5 | 2.0% | 70.4% |
15 | MeVPMe6 (L) | Glu | 31 | 15.5 | 2.0% | 72.4% |
16 | Tm5c (R) | Glu | 29 | 14.5 | 1.9% | 74.3% |
17 | HBeyelet (R) | His | 28 | 14.0 | 1.8% | 76.1% |
18 | MeTu3b (R) | ACh | 23 | 11.5 | 1.5% | 77.6% |
19 | aMe12 (R) | ACh | 22 | 11.0 | 1.4% | 79.1% |
20 | Dm2 (R) | ACh | 21 | 10.5 | 1.4% | 80.4% |
21 | aMe4 (R) | ACh | 18 | 9.0 | 1.2% | 81.6% |
22 | Tm5b (R) | ACh | 17 | 8.5 | 1.1% | 82.7% |
23 | Dm8b (R) | Glu | 14 | 7.0 | 0.9% | 83.6% |
24 | aMe1 (R) | GABA | 13 | 6.5 | 0.8% | 84.5% |
25 | Cm8 (R) | GABA | 12 | 6.0 | 0.8% | 85.2% |
26 | MeLo4 (R) | ACh | 12 | 6.0 | 0.8% | 86.0% |
27 | MeVPMe5 (L) | Glu | 12 | 6.0 | 0.8% | 86.8% |
28 | MeVP6 (R) | Glu | 11 | 5.5 | 0.7% | 87.5% |
29 | Tm39 (R) | ACh | 11 | 5.5 | 0.7% | 88.2% |
30 | Cm20 (R) | GABA | 10 | 5.0 | 0.7% | 88.9% |
31 | Lat3 (R) | unclear | 10 | 5.0 | 0.7% | 89.5% |
32 | Cm31b (R) | GABA | 9 | 4.5 | 0.6% | 90.1% |
33 | aMe10 (R) | ACh | 8 | 4.0 | 0.5% | 90.6% |
34 | Cm17 (R) | GABA | 8 | 4.0 | 0.5% | 91.2% |
35 | OA-AL2i3 (R) | OA | 7 | 3.5 | 0.5% | 91.6% |
36 | aMe24 (R) | unclear | 6 | 3.0 | 0.4% | 92.0% |
37 | Cm21 (R) | GABA | 6 | 3.0 | 0.4% | 92.4% |
38 | Cm3 (R) | GABA | 6 | 3.0 | 0.4% | 92.8% |
39 | Cm4 (R) | Glu | 6 | 3.0 | 0.4% | 93.2% |
40 | MeVP3 (R) | ACh | 6 | 3.0 | 0.4% | 93.6% |
41 | MeVPaMe2 (L) | Glu | 6 | 3.0 | 0.4% | 94.0% |
42 | MeVPMe7 (L) | Glu | 6 | 3.0 | 0.4% | 94.3% |
43 | Tm29 (R) | Glu | 6 | 3.0 | 0.4% | 94.7% |
44 | Cm26 (R) | Glu | 4 | 2.0 | 0.3% | 95.0% |
45 | Cm31a (R) | GABA | 4 | 2.0 | 0.3% | 95.3% |
46 | MeTu3c (R) | ACh | 4 | 2.0 | 0.3% | 95.5% |
47 | MeVP9 (R) | ACh | 4 | 2.0 | 0.3% | 95.8% |
48 | aMe12 (L) | ACh | 3 | 1.5 | 0.2% | 96.0% |
49 | Cm1 (R) | ACh | 3 | 1.5 | 0.2% | 96.2% |
50 | Cm_unclear (R) | ACh | 3 | 1.5 | 0.2% | 96.4% |
51 | l-LNv (R) | unclear | 3 | 1.5 | 0.2% | 96.6% |
52 | MeVP1 (R) | ACh | 3 | 1.5 | 0.2% | 96.7% |
53 | MeVP11 (R) | ACh | 3 | 1.5 | 0.2% | 96.9% |
54 | MeVP48 (R) | unclear | 3 | 1.5 | 0.2% | 97.1% |
55 | MeVPMe11 (L) | Glu | 3 | 1.5 | 0.2% | 97.3% |
56 | Tm3 (R) | ACh | 3 | 1.5 | 0.2% | 97.5% |
57 | Cm25 (R) | Glu | 2 | 1.0 | 0.1% | 97.7% |
58 | Cm7 (R) | Glu | 2 | 1.0 | 0.1% | 97.8% |
59 | MeVP25 (R) | unclear | 2 | 1.0 | 0.1% | 97.9% |
60 | MeVP40 (R) | unclear | 2 | 1.0 | 0.1% | 98.0% |
instance | NT | total connections | connections /#aMe10 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | aMe4 (R) | ACh | 88 | 44.0 | 20.2% | 20.2% |
1 | aMe5 (R) | ACh | 57 | 28.5 | 13.1% | 33.3% |
2 | Cm21 (R) | GABA | 54 | 27.0 | 12.4% | 45.6% |
3 | Cm9 (R) | Glu | 37 | 18.5 | 8.5% | 54.1% |
4 | aMe1 (R) | GABA | 14 | 7.0 | 3.2% | 57.3% |
5 | Cm25 (R) | Glu | 14 | 7.0 | 3.2% | 60.6% |
6 | aMe15 (R) | unclear | 13 | 6.5 | 3.0% | 63.5% |
7 | MeVPaMe2 (R) | Glu | 11 | 5.5 | 2.5% | 66.1% |
8 | aMe17b (R) | GABA | 10 | 5.0 | 2.3% | 68.3% |
9 | MeVPaMe2 (L) | Glu | 10 | 5.0 | 2.3% | 70.6% |
10 | Cm24 (R) | Glu | 9 | 4.5 | 2.1% | 72.7% |
11 | MeVPMe5 (R) | Glu | 9 | 4.5 | 2.1% | 74.8% |
12 | aMe10 (R) | ACh | 8 | 4.0 | 1.8% | 76.6% |
13 | aMe2 (R) | Glu | 7 | 3.5 | 1.6% | 78.2% |
14 | s-LNv (R) | unclear | 7 | 3.5 | 1.6% | 79.8% |
15 | aMe6b (R) | ACh | 6 | 3.0 | 1.4% | 81.2% |
16 | LoVP38 (R) | Glu | 6 | 3.0 | 1.4% | 82.6% |
17 | MeVPMe9 (R) | Glu | 6 | 3.0 | 1.4% | 83.9% |
18 | aMe3 (R) | Glu | 5 | 2.5 | 1.1% | 85.1% |
19 | Lat5 (R) | unclear | 5 | 2.5 | 1.1% | 86.2% |
20 | Cm30 (R) | GABA | 4 | 2.0 | 0.9% | 87.2% |
21 | Tm38 (R) | ACh | 4 | 2.0 | 0.9% | 88.1% |
22 | Tm35 (R) | Glu | 3 | 1.5 | 0.7% | 88.8% |
23 | Tm5c (R) | Glu | 3 | 1.5 | 0.7% | 89.4% |
24 | aMe23 (R) | unclear | 2 | 1.0 | 0.5% | 89.9% |
25 | Cm11c (R) | ACh | 2 | 1.0 | 0.5% | 90.4% |
26 | Cm12 (R) | GABA | 2 | 1.0 | 0.5% | 90.8% |
27 | Cm5 (R) | GABA | 2 | 1.0 | 0.5% | 91.3% |
28 | PLP211 (R) | unclear | 2 | 1.0 | 0.5% | 91.7% |
29 | Tm31 (R) | Glu | 2 | 1.0 | 0.5% | 92.2% |
30 | Tm37 (R) | Glu | 2 | 1.0 | 0.5% | 92.7% |
31 | Tm39 (R) | ACh | 2 | 1.0 | 0.5% | 93.1% |